Sex-specific Differences in Hepatic Steatosis in Obese Spontaneously Hypertensive (SHROB) Rats

Overview

Journal Biol Sex Differ

Publisher Biomed Central

Specialties Biology
Physiology

Date 2018 Sep 12

PMID 30201044

Citations 6

Authors

Qingming Dong

Michael S Kuefner

Xiong Deng

Dave Bridges

Edwards A Park

Marshall B Elam

Rajendra Raghow

Affiliations

Soon will be listed here.

Abstract

Background: Patients with metabolic syndrome, who are characterized by co-existence of insulin resistance, hypertension, hyperlipidemia, and obesity, are also prone to develop non-alcoholic fatty liver disease (NAFLD). Although the prevalence and severity of NAFLD is significantly greater in men than women, the mechanisms by which gender modulates the pathogenesis of hepatic steatosis are poorly defined. The obese spontaneously hypertensive (SHROB) rats represent an attractive model of metabolic syndrome without overt type 2 diabetes. Although pathological manifestation caused by the absence of a functional leptin receptor has been extensively studied in SHROB rats, it is unknown whether these animals elicited sex-specific differences in the development of hepatic steatosis.

Methods: We compared hepatic pathology in male and female SHROB rats. Additionally, we examined key biochemical and molecular parameters of signaling pathways linked with hyperinsulinemia and hyperlipidemia. Finally, using methods of quantitative polymerase chain reaction (qPCR) and western blot analysis, we quantified expression of 45 genes related to lipid biosynthesis and metabolism in the livers of male and female SHROB rats.

Results: We show that all SHROB rats developed hepatic steatosis that was accompanied by enhanced expression of SREBP1, SREBP2, ACC1, and FASN proteins. The livers of male rats also elicited higher induction of Pparg, Ppara, Slc2a4, Atox1, Skp1, Angptl3, and Pnpla3 mRNAs. In contrast, the livers of female SHROB rats elicited constitutively higher levels of phosphorylated JNK and AMPK and enhanced expression of Cd36.

Conclusion: Based on these data, we conclude that the severity of hepatic steatosis in male and female SHROB rats was mainly driven by increased de novo lipogenesis. Moreover, male and female SHROB rats also elicited differential severity of hepatic steatosis that was coupled with sex-specific differences in fatty acid transport and esterification.

Citing Articles

The Role of Solute Carrier Family Transporters in Hepatic Steatosis and Hepatic Fibrosis.

Zhang C, Yang X, Xue Y, Li H, Zeng C, Chen M J Clin Transl Hepatol. 2025; 13(3):233-252.

PMID: 40078199 PMC: 11894391. DOI: 10.14218/JCTH.2024.00348.

Sex differences in murine MASH induced by a fructose-palmitate-cholesterol-enriched diet.

Arivazhagan L, Delbare S, Wilson R, Manigrasso M, Zhou B, Ruiz H JHEP Rep. 2025; 7(2):101222.

PMID: 39911943 PMC: 11795143. DOI: 10.1016/j.jhepr.2024.101222.

A Review of Animal Models for Studying Bone Health in Type-2 Diabetes Mellitus (T2DM) and Obesity.

Norazman S, Mohd Zaffarin A, Shuid A, Hassan H, Soleiman I, Kuan W Int J Mol Sci. 2024; 25(17).

PMID: 39273348 PMC: 11394783. DOI: 10.3390/ijms25179399.

Glutathione Levels and Lipid Oxidative Damage in Selected Organs of Obese Koletsky and Lean Spontaneously Hypertensive Rats.

Rauchova H, Neprasova B, Maletinska L, Kunes J Physiol Res. 2024; 73(3):481-484.

PMID: 39027962 PMC: 11299778. DOI: 10.33549/physiolres.935319.

Genetic or pharmacological GHSR blockade has sexually dimorphic effects in rodents on a high-fat diet.

Leko A, Gregory-Flores A, Marchette R, Gomez J, Vendruscolo J, Repunte-Canonigo V Commun Biol. 2024; 7(1):632.

PMID: 38796563 PMC: 11127961. DOI: 10.1038/s42003-024-06303-5.

References

Mintziori G, Poulakos P, Tsametis C, Goulis D . Hypogonadism and non-alcoholic fatty liver disease. Minerva Endocrinol. 2016; 42(2):145-150. DOI: 10.23736/S0391-1977.16.02570-0. View

Chao L, MASON M, Moitra J, Vinson C, Arioglu E, Gavrilova O . Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest. 2000; 106(10):1221-8. PMC: 381440. DOI: 10.1172/JCI11245. View

Smith B, Steinberg G . AMP-activated protein kinase, fatty acid metabolism, and insulin sensitivity. Curr Opin Clin Nutr Metab Care. 2017; 20(4):248-253. DOI: 10.1097/MCO.0000000000000380. View

Onoyama I, Suzuki A, Matsumoto A, Tomita K, Katagiri H, Oike Y . Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver. J Clin Invest. 2010; 121(1):342-54. PMC: 3007132. DOI: 10.1172/JCI40725. View

Matsusue K, Haluzik M, Lambert G, Yim S, Gavrilova O, Ward J . Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest. 2003; 111(5):737-47. PMC: 151902. DOI: 10.1172/JCI17223. View

Raghow R . An 'Omics' Perspective on Cardiomyopathies and Heart Failure. Trends Mol Med. 2016; 22(9):813-827. DOI: 10.1016/j.molmed.2016.07.007. View

Hu E, Kim J, Sarraf P, Spiegelman B . Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science. 1996; 274(5295):2100-3. DOI: 10.1126/science.274.5295.2100. View

Norheim F, Hui S, Kulahcioglu E, Mehrabian M, Cantor R, Pan C . Genetic and hormonal control of hepatic steatosis in female and male mice. J Lipid Res. 2016; 58(1):178-187. PMC: 5234719. DOI: 10.1194/jlr.M071522. View

Huang Y, He S, Li J, Seo Y, Osborne T, Cohen J . A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc Natl Acad Sci U S A. 2010; 107(17):7892-7. PMC: 2867902. DOI: 10.1073/pnas.1003585107. View

10.

Mehlem A, Hagberg C, Muhl L, Eriksson U, Falkevall A . Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat Protoc. 2013; 8(6):1149-54. DOI: 10.1038/nprot.2013.055. View

11.

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J . Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372(6505):425-32. DOI: 10.1038/372425a0. View

12.

ODea K, KOLETSKY S . Effect of caloric restriction on basal insulin levels and the in vivo lipogenesis and glycogen synthesis from glucose in the Koletsky obese rat. Metabolism. 1977; 26(7):763-72. DOI: 10.1016/0026-0495(77)90063-4. View

13.

Inukai K, Nakashima Y, Watanabe M, Kurihara S, Awata T, Katagiri H . ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states. Biochem Biophys Res Commun. 2004; 317(4):1075-9. DOI: 10.1016/j.bbrc.2004.03.151. View

14.

Ahmadian M, Suh J, Hah N, Liddle C, Atkins A, Downes M . PPARγ signaling and metabolism: the good, the bad and the future. Nat Med. 2013; 19(5):557-66. PMC: 3870016. DOI: 10.1038/nm.3159. View

15.

Mitsche M, Hobbs H, Cohen J . Patatin-like phospholipase domain–containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets. J Biol Chem. 2018; 293(18):6958-6968. PMC: 5936833. DOI: 10.1074/jbc.RA118.002333. View

16.

Glazier A, Scott J, Aitman T . Molecular basis of the Cd36 chromosomal deletion underlying SHR defects in insulin action and fatty acid metabolism. Mamm Genome. 2002; 13(2):108-13. DOI: 10.1007/s00335-001-2132-9. View

17.

Shimamura M, Matsuda M, Ando Y, Koishi R, Yasumo H, Furukawa H . Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor. Biochem Biophys Res Commun. 2004; 322(3):1080-5. DOI: 10.1016/j.bbrc.2004.08.024. View

18.

KOLETSKY S . Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol. 1975; 80(1):129-42. PMC: 1912834. View

19.

Kotzka J, Muller-Wieland D, Roth G, Kremer L, Munck M, Schurmann S . Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade. J Lipid Res. 2000; 41(1):99-108. View

20.

Yang S, Yates P, Whitmarsh A, Davis R, Sharrocks A . The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif. Mol Cell Biol. 1998; 18(2):710-20. PMC: 108782. DOI: 10.1128/MCB.18.2.710. View